Nunzia Pharmaceutical Co. – ‘10-Q’ for 3/31/22 – ‘EXCEL’

On:  Monday, 5/23/22, at 7:33am ET   ·   For:  3/31/22   ·   Accession #:  1683168-22-3887   ·   File #:  1-39175

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    225K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     15K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     15K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     12K 
10: R1          Cover                                               HTML     59K 
11: R2          Consolidated Balance Sheets (Unaudited)             HTML     74K 
12: R3          Consolidated Balance Sheets (Unaudited)             HTML     22K 
                (Parenthetical)                                                  
13: R4          Consolidated Statements of Operations (Unaudited)   HTML     90K 
14: R5          Consolidated Statements of Cash Flows (Unaudited)   HTML     53K 
15: R6          Basis of Presentation, Organization, Going Concern  HTML     21K 
                and Recent Accounting Pronouncements                             
16: R7          Summary of Significant Accounting Policies          HTML     30K 
17: R8          Preferred and Common Stock                          HTML     22K 
18: R9          Commitments and Contingencies                       HTML     18K 
19: R10         Transactions with Related Persons                   HTML     18K 
20: R11         Subsequent Events                                   HTML     14K 
21: R12         Summary of Significant Accounting Policies          HTML     57K 
                (Policies)                                                       
22: R13         Basis of Presentation, Organization, Going Concern  HTML     15K 
                and Recent Accounting Pronouncements (Details                    
                Narrative)                                                       
23: R14         Summary of Significant Accounting Policies          HTML     14K 
                (Details Narrative)                                              
24: R15         Preferred and Common Stock (Details Narrative)      HTML     32K 
25: R16         Transactions with Related Persons (Details          HTML     26K 
                Narrative)                                                       
28: XML         IDEA XML File -- Filing Summary                      XML     44K 
26: XML         XBRL Instance -- nunzia_i10q-033122_htm              XML    203K 
27: EXCEL       IDEA Workbook of Financial Reports                  XLSX     30K 
 6: EX-101.CAL  XBRL Calculations -- nunz-20220331_cal               XML     51K 
 7: EX-101.DEF  XBRL Definitions -- nunz-20220331_def                XML    112K 
 8: EX-101.LAB  XBRL Labels -- nunz-20220331_lab                     XML    274K 
 9: EX-101.PRE  XBRL Presentations -- nunz-20220331_pre              XML    213K 
 5: EX-101.SCH  XBRL Schema -- nunz-20220331                         XSD     39K 
29: JSON        XBRL Instance as JSON Data -- MetaLinks              126±   162K 
30: ZIP         XBRL Zipped Folder -- 0001683168-22-003887-xbrl      Zip     54K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/21  Nunzia Pharmaceutical Co.         8-K©:1      8/03/21    1:27K                                    1562884
 5/07/21  Nunzia Pharmaceutical Co.         8-K©:1      4/12/21    1:337K                                   1562884